Primerica, Inc. (PRI) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates a positive outlook, with strong growth in the ISP segment, expansion in the mortgage business, and significant technology investments. The Q&A section reveals easing cost of living pressures and stable term life margins, with a focus on improving sales force growth and term sales initiatives. Additionally, the company plans increased shareholder returns through buybacks and dividends. Despite some uncertainties and competition, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8%.
Key Financial Performance
Adjusted Net Operating Income (Q4 2025) $751 million, a 10% increase year-over-year. This growth reflects the benefit and balance of fee-based businesses and the Term Life business.
Diluted Adjusted Operating Income Per Share (Q4 2025) $22.92, a 16% increase year-over-year. This was driven by strong earnings growth and operational efficiency.
Total In-Force Protection $968 billion, a record high. This reflects the strength and stability of the business model.
Client Asset Values $129 billion, a 15% increase year-over-year. This was supported by solid annual net inflows of $1.7 billion and equity market momentum.
Investment and Savings Product Sales (Q4 2025) $4.1 billion, a 24% increase year-over-year. Growth was driven by strong demand across all major product lines and favorable demographic trends.
Investment and Savings Product Sales (Full Year 2025) $14.9 billion, a 24% increase year-over-year. This was supported by retirement savings needs and increased interest in managed account platforms.
Mortgage Loan Volume (2025) $500 million, a 26% increase year-over-year. Growth was driven by refinancing opportunities and new mortgages in the U.S. and Canada.
Adjusted Operating Revenues (2025) $3.3 billion, an 8% increase year-over-year. This reflects strong performance across all major segments.
Return on Adjusted Equity (2025) 33.1%, a 200 basis point increase year-over-year. This was led by growth in the investment and savings product segment.
Term Life New Policies Issued (Full Year 2025) 76,143 policies, a 10% decline year-over-year. This was impacted by higher cost of living pressures.
Term Life Annualized Issued Premiums (Full Year 2025) Declined 7% year-over-year. This reflects a decrease in new policies issued and coverage additions.
Term Life Revenue Growth (Q4 2025) $457 million in adjusted direct premiums, with a 5% increase in pretax income. Growth was driven by recurring premiums and remeasurement gains.
Benefits and Claims Ratio (Q4 2025) 57.8%, compared to 58.6% in the prior year. This improvement was due to favorable mortality experience and lower persistency.
ISP Operating Revenues (Q4 2025) $340 million, a 19% increase year-over-year. Growth was driven by equity market appreciation and higher demand for variable annuities.
ISP Pretax Income (Q4 2025) $101 million, a 23% increase year-over-year. This was supported by strong sales activity and favorable product mix shifts.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Term Life Policies: Issued 76,143 new policies in Q4 2025, providing $26 billion of new term life protection. However, the number of new policies issued declined 10% year-over-year.
Investment and Savings Products (ISP): Sales reached $4.1 billion in Q4 2025, up 24% year-over-year. Full-year sales totaled $14.9 billion, also up 24%. Growth driven by strong demand across all major product lines and favorable demographic trends.
Mortgage Loans: Closed over $500 million in mortgage loan volume in the U.S. in 2025, a 26% increase year-over-year. Canadian mortgage referral program saw an 18% growth in volume.
Financial Performance: Record adjusted operating revenues of $3.3 billion in 2025, up 8%. Adjusted net operating income increased 10% to $751 million. Earnings per share grew 16% to $22.92.
Investment and Savings Products (ISP) Segment: ISP represented 38% of consolidated operating revenues in 2025, up from 32% in 2022. Pretax income for Q4 2025 increased 23% to $101 million.
Recruiting and Licensing: Recruiting and licensing activity declined in 2025 due to economic uncertainty but is expected to grow in 2026, with a projected 1% growth in the life license sales force.
Balanced Business Growth: Focus on growing across all major product lines and strengthening recruiting and licensing to expand distribution footprint in 2026.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Recruiting and Licensing Activity: Recruiting and licensing activity declined in 2025 compared to 2024, reflecting economic uncertainty and challenging comparisons to record-setting activity in 2024. This could impact the growth of the life-licensed sales force and overall distribution capabilities.
Term Life Insurance Sales: The number of new policies issued declined by 10% in 2025 compared to 2024, and annualized issued premiums declined by 7%. Cost of living pressures adversely impacted demand for Term Life insurance coverage, posing a challenge to revenue growth in this segment.
Equity Market Sensitivity: The Investment and Savings Products (ISP) segment, while growing, remains sensitive to equity market conditions. Elevated market uncertainty could adversely impact sales growth and client asset values.
Persistency and Lapse Rates: Lapse rates for Term Life insurance policies remain elevated relative to long-term reserve assumptions, although stable year-over-year. Persistency issues could affect revenue stability and long-term profitability.
Economic Pressures on Middle-Income Families: Economic pressures, including cost of living challenges, have impacted middle-income families, leading to elevated lapse rates and reduced demand for certain financial products. This could hinder growth in key business segments.
Technology Investment Costs: Increased technology investments have led to higher operating expenses, which could pressure margins if revenue growth does not offset these costs.
Regulatory and Interest Rate Risks: The company’s investment portfolio has unrealized losses due to interest rate fluctuations. While these are not credit-related, they reflect sensitivity to macroeconomic conditions, which could impact financial stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Recruiting and Licensing Growth: The company expects full year growth in both recruiting and licensing, translating into approximately 1% growth in the life license sales force in 2026.
Term Life Policy Growth: Cost of living pressures are expected to ease, with wage growth outpacing inflation. The company maintains a conservative outlook for full year policy growth during 2026 in the 2% to 3% range.
Investment and Savings Product (ISP) Sales Growth: Sales growth is projected at around 5% to 7% during 2026, supported by favorable demographic trends and strong demand for retirement solutions and investment options.
Mortgage Loan Volume: The company remains well-positioned to help middle-income families with new mortgages or refinancing. Growth in mortgage loan volume is expected to continue, building on the 26% increase seen in 2025.
Adjusted Direct Premiums Growth: Adjusted direct premiums are expected to grow approximately 4% in 2026, with stable key financial ratios and operating margins around 21%.
Consolidated Expenses: Full year 2026 consolidated expenses are expected to grow around 7% to 8%, with first-quarter expenses slightly higher due to annual equity compensation vesting.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Payments: Primerica returned approximately 79% of net operating income through a combination of share repurchases and dividend payments in 2025. This level of return is typically well above life and health insurance peers, highlighting the company's capital-light and disciplined approach to capital deployment.
Share Repurchases: Primerica returned approximately 79% of net operating income through a combination of share repurchases and dividend payments in 2025. This level of return is typically well above life and health insurance peers, highlighting the company's capital-light and disciplined approach to capital deployment.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is driving the 2% to 3% term sales growth outlook for 2026?
A:The growth is driven by increasing momentum anticipated throughout the year, improved purchasing power for middle-income families, and easing cost of living pressures. The company's household budget index showed consistent improvement in 2025, indicating purchasing power outstripping the cost of living for middle-income families.
Q:Why are there diverging trends between term sales and ISP (Investment and Savings Products)?
A:The divergence is due to different segments of the middle-income market reacting differently to conditions. The investment business benefits from money in motion, particularly to annuities with income guarantees, while term insurance buyers are often first-time purchasers with tighter budgets. The two segments complement each other, with one being strong when the other is weak.
Q:What is the potential impact of AI on the business model, especially regarding salespeople?
A:AI is seen as an opportunity to improve efficiencies and reshape workflows in home office processing and sales processes. The company already uses AI in licensing, training tools, translation, financial needs analysis, and client apps. However, AI is not seen as a threat to the business model due to the importance of personal relationships, empathy, and motivation provided by human representatives.
Q:What are the distractions in the middle market, and are they easing?
A:Distractions include tight budgets, equity market volatility, and economic and political uncertainties. Cost of living pressures are easing as wages outstrip living costs, providing more economic breathing room. People are becoming more accustomed to uncertainties, which may reduce distractions and provide opportunities for term sales growth.
Q:What is the progress of initiatives to improve term sales, such as product changes and faster underwriting?
A:The company is focusing on changing messaging and training to help representatives navigate tight budgets. They are encouraging reps to proactively engage with families to identify budget breathing room and prioritize financial protection and investment. It is too early to measure the impact of these initiatives, but they are expected to have a positive effect during the year.
Q:What is the outlook for sales force growth in 2026 and beyond?
A:The company expects 1% growth in the sales force in 2026, with potential for higher growth in the future. Growth drivers include improved recruiting, licensing rates, and retention. The sales force size is seen as scalable, with demand for the opportunity remaining strong. Attrition rates are stable, and the company is confident in its ability to grow the sales force.
Q:Are cost of living pressures easing, and is this reflected in sales or recruiting growth metrics?
A:Cost of living pressures are easing, and January results were encouraging, though it is too early to determine the full impact on sales or recruiting growth metrics. The company remains conservative in its projections but believes there is an opportunity to capitalize on improving conditions.
Q:What is the outlook for Term Life margins in 2026?
A:The Term Life margin is guided at 21% for 2026, slightly below recent years. The benefit and claims ratio is stable, with net investment income offsetting reserve increases. DAC (Deferred Acquisition Costs) and commission dynamics are influenced by growth rates, but overall, the business is stable and sustainable.
Q:What is the impact of shifting demographics and internal focus on ISP versus Term Life?
A:Shifting demographics and internal focus naturally lead to more attention on ISP when it is strong, as it is currently. The ISP business attracts more experienced representatives, while younger representatives focus on term insurance. The company emphasizes the importance of both segments and expects term insurance to regain momentum over time.
Q:What is the expense outlook for 2026?
A:The expense outlook for 2026 is 7% to 8% growth. Investments are being made in sales training, technology, and infrastructure to support growth in securities and term businesses. The company is focused on maintaining high service levels and supporting long-term growth.
Q:What are the potential headwinds for ISP sales, such as competition from 401(k) providers and in-plan guarantees?
A:Competition from 401(k) providers and in-plan guarantees could pose headwinds, but the company believes its advantage lies in deep client relationships, personalized service, and motivation provided by representatives. These factors are expected to help overcome potential challenges.
Q:How does increased competition among annuity providers impact ISP sales?
A:Increased competition among annuity providers leads to better product value for clients, such as improved guarantees and flexibility. Compensation for representatives is not expected to change significantly, but better products enhance client value and support ISP sales.
Q:What is the free cash flow conversion outlook, and how is excess capital being managed?
A:The company maintains a strong free cash flow conversion rate of around 80%. Excess capital from life subsidiaries has been drawn down to support increased shareholder returns, including a $475 million buyback and a 15% dividend increase. Investments are also being made in organic growth and infrastructure.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on January growth rates relative to 2026 guidance, stating they would provide more information in the first quarter report. Additionally, they did not quantify the substitution effect between ISP and Term Life sales or provide specific metrics on the impact of initiatives to improve term sales.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Canada representative
Greetings Primerica
Highlights result
ISP demand
ISP result
Life cost
Officer press
Preliminary result
Primerica Webcast
Primerica cash
Primerica copy
Primerica household
ROAE Highlights
Relations Primerica
Relations comment
Sales result
Stockholders capital
Term Life
Webcast Instructions
activity basis
activity life
addition policy
anniversary groundwork
annuity solution
client term
coverage
effort
equity market
goal
improvement
income share
increase income
inflation
investment saving
product sale
protection client
record
saving product
stability
volume
wage
PRI Transcript
Primerica, Inc. (PRI) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call summary reflects a positive sentiment due to the projected growth in various segments, such as recruiting, licensing, term life policy, and ISP sales. The Q&A session reinforced this positive outlook, with management expressing confidence in stabilizing term life sales and ISP growth, despite some economic uncertainties. The shift towards AUM-based fees and the strong annuity sales growth also contribute positively. However, the slight increase in expenses and the operating loss in corporate products are concerns, but overall, the sentiment remains positive due to growth and strategic initiatives.
Primerica, Inc. (PRI) Q4 2025 Earnings Call Transcript
Positive2-12
The earnings call summary indicates a positive outlook, with strong growth in the ISP segment, expansion in the mortgage business, and significant technology investments. The Q&A section reveals easing cost of living pressures and stable term life margins, with a focus on improving sales force growth and term sales initiatives. Additionally, the company plans increased shareholder returns through buybacks and dividends. Despite some uncertainties and competition, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8%.
Primerica, Inc. (PRI) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call presents a mixed outlook. While there is optimism in ISP sales and annuity growth driven by demographics, the expected decline in new life policies and increased expenses are concerns. The Q&A highlights uncertainties in Term Life sales and government policy impacts, with management providing limited specifics on certain issues. The balance between positive and negative factors suggests a neutral stock price movement in the short term.
Primerica, Inc. (PRI) Q2 2025 Earnings Call Transcript
Neutral8-8
PRI Slides
PRI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
